Composition and methods for treating an aneurysm
US-2024390403-A1 · Nov 28, 2024 · US
Solution for tissue adhesion prevention and method for tissue adhesion prevention
US9155751B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9155751-B2 |
| Application number | US-201113047551-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 14, 2011 |
| Priority date | Jun 8, 2005 |
| Publication date | Oct 13, 2015 |
| Grant date | Oct 13, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The objective of the invention is to provide a solution for tissue adhesion prevention and a method for tissue adhesion prevention that are applicable to general surgery and in which covering condition during surgery is stable and convenient. The invention is the solution for tissue adhesion prevention of which the active ingredient is trehalose. Also, it contains at least one or more among antioxidants, chelates, antiseptics, hemostatics, anti-inflammatory agents, and polysaccharides, mucopolysaccharides, salts of polysaccharides and salts of mucopolysaccharides having lubricating properties. This solution for tissue adhesion prevention is provided as any form of perfusion fluid, spray fluid, solution for spray or vaporization administration, foam-like aerosol preparation, injection solution for intravenous fluids, intravenous fluid.
First claim
Opening claim text (preview).
The invention claimed is: 1. The method for tissue adhesion prevention, comprising: locally applying a solution comprising alpha, alpha-trehalose to living tissues exposed to air during surgery, wherein the solution for tissue adhesion prevention comprises alpha, alpha-trehalose in an amount effective to provide a cell membrane phospholipid-protecting effect and to prevent tissue adhesion following the surgery. 2. The method for tissue adhesion prevention acc…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
- A61K31/7016Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9155751B2 cover?
- The objective of the invention is to provide a solution for tissue adhesion prevention and a method for tissue adhesion prevention that are applicable to general surgery and in which covering condition during surgery is stable and convenient. The invention is the solution for tissue adhesion prevention of which the active ingredient is trehalose. Also, it contains at least one or more among ant…
- Who is the assignee on this patent?
- Suzuki Shigeki, Miwa Yoshikatsu, Sasaki Nobuo, and 4 more
- What technology area does this patent fall under?
- Primary CPC classification A61K31/7016. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).